(ECVT) Ecovyst - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US27923Q1094
Stock: Catalysts, Silicas, Zeolites, Sulfuric Acid
Total Rating 56
Risk 71
Buy Signal 0.72
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 36.5% |
| Relative Tail Risk | -6.65% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.90 |
| Alpha | 21.41 |
| Character TTM | |
|---|---|
| Beta | 1.183 |
| Beta Downside | 1.282 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.74% |
| CAGR/Max DD | 0.01 |
Description: ECVT Ecovyst January 20, 2026
Ecovyst Inc. (NYSE: ECVT) operates two business lines: Ecoservices, which recycles sulfuric acid and provides logistics for alkylate production and supplies virgin sulfuric acid to mining, water-treatment and industrial markets; and Advanced Materials & Catalysts, which manufactures specialty catalysts, advanced silicas and zeolite products for polyethylene producers, oil refiners (hydrocracking, dewaxing), sustainable-fuel processes and diesel-engine emission controls. The company, formerly PQ Group Holdings, rebranded in August 2021 and traces its roots back to 1831, with headquarters in Malvern, Pennsylvania.
Key market drivers include: (1) global refining margins, which directly affect demand for hydrocracking and dewaxing catalysts; (2) the accelerating shift toward low-sulfur diesel and renewable-fuel blends, boosting sales of emission-control zeolite catalysts; and (3) recent quarterly filings show ECVT’s revenue grew ~7% YoY to $210 million, with an adjusted EBITDA margin of roughly 12%, indicating modest but improving profitability amid a tightening specialty-chemicals supply chain.
For a deeper quantitative view, see the ValueRay analysis of ECVT.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: -192.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.01 > 1.0 |
| NWC/Revenue: 21.88% < 20% (prev 24.70%; Δ -2.81% < -1%) |
| CFO/TA 0.09 > 3% & CFO 164.3m > Net Income -192.6m |
| Net Debt (772.8m) to EBITDA (66.8m): 11.57 < 3 |
| Current Ratio: 2.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (114.0m) vs 12m ago -2.70% < -2% |
| Gross Margin: 24.37% > 18% (prev 0.28%; Δ 2409 % > 0.5%) |
| Asset Turnover: 42.18% > 50% (prev 37.79%; Δ 4.39% > 0%) |
| Interest Coverage Ratio: 0.26 > 6 (EBITDA TTM 66.8m / Interest Expense TTM 39.6m) |
Altman Z'' -0.05
| A: 0.10 (Total Current Assets 297.1m - Total Current Liabilities 132.1m) / Total Assets 1.73b |
| B: -0.15 (Retained Earnings -254.4m / Total Assets 1.73b) |
| C: 0.01 (EBIT TTM 10.1m / Avg Total Assets 1.79b) |
| D: -0.23 (Book Value of Equity -254.4m / Total Liabilities 1.13b) |
| Altman-Z'' Score: -0.05 = B |
Beneish M -3.00
| DSRI: 1.04 (Receivables 83.3m/74.0m, Revenue 754.0m/695.3m) |
| GMI: 1.15 (GM 24.37% / 28.03%) |
| AQI: 1.01 (AQ_t 0.53 / AQ_t-1 0.52) |
| SGI: 1.08 (Revenue 754.0m / 695.3m) |
| TATA: -0.21 (NI -192.6m - CFO 164.3m) / TA 1.73b) |
| Beneish M-Score: -3.00 (Cap -4..+1) = AA |
What is the price of ECVT shares?
As of February 07, 2026, the stock is trading at USD 11.05 with a total of 888,669 shares traded.
Over the past week, the price has changed by +4.15%, over one month by +8.33%, over three months by +32.34% and over the past year by +38.30%.
Over the past week, the price has changed by +4.15%, over one month by +8.33%, over three months by +32.34% and over the past year by +38.30%.
Is ECVT a buy, sell or hold?
Ecovyst has received a consensus analysts rating of 4.67.
Therefore, it is recommended to buy ECVT.
- StrongBuy: 4
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ECVT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12 | 8.6% |
| Analysts Target Price | 12 | 8.6% |
| ValueRay Target Price | 12.8 | 15.9% |
ECVT Fundamental Data Overview February 03, 2026
P/E Forward = 19.6464
P/S = 1.5581
P/B = 2.0295
Revenue TTM = 754.0m USD
EBIT TTM = 10.1m USD
EBITDA TTM = 66.8m USD
Long Term Debt = 846.1m USD (from longTermDebt, last quarter)
Short Term Debt = 8.73m USD (from shortLongTermDebt, last quarter)
Debt = 899.2m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 772.8m USD (from netDebt column, last quarter)
Enterprise Value = 2.03b USD (1.21b + Debt 899.2m - CCE 82.0m)
Interest Coverage Ratio = 0.26 (Ebit TTM 10.1m / Interest Expense TTM 39.6m)
EV/FCF = 17.12x (Enterprise Value 2.03b / FCF TTM 118.6m)
FCF Yield = 5.84% (FCF TTM 118.6m / Enterprise Value 2.03b)
FCF Margin = 15.73% (FCF TTM 118.6m / Revenue TTM 754.0m)
Net Margin = -25.54% (Net Income TTM -192.6m / Revenue TTM 754.0m)
Gross Margin = 24.37% ((Revenue TTM 754.0m - Cost of Revenue TTM 570.2m) / Revenue TTM)
Gross Margin QoQ = 25.41% (prev 25.43%)
Tobins Q-Ratio = 1.17 (Enterprise Value 2.03b / Total Assets 1.73b)
Interest Expense / Debt = 0.93% (Interest Expense 8.37m / Debt 899.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = 8.01m (EBIT 10.1m * (1 - 21.00%))
Current Ratio = 2.25 (Total Current Assets 297.1m / Total Current Liabilities 132.1m)
Debt / Equity = 1.48 (Debt 899.2m / totalStockholderEquity, last quarter 607.9m)
Debt / EBITDA = 11.57 (Net Debt 772.8m / EBITDA 66.8m)
Debt / FCF = 6.51 (Net Debt 772.8m / FCF TTM 118.6m)
Total Stockholder Equity = 653.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -10.77% (Net Income -192.6m / Total Assets 1.73b)
RoE = -29.46% (Net Income TTM -192.6m / Total Stockholder Equity 653.7m)
RoCE = 0.68% (EBIT 10.1m / Capital Employed (Equity 653.7m + L.T.Debt 846.1m))
RoIC = 0.52% (NOPAT 8.01m / Invested Capital 1.53b)
WACC = 6.21% (E(1.21b)/V(2.11b) * Re(10.27%) + D(899.2m)/V(2.11b) * Rd(0.93%) * (1-Tc(0.21)))
Discount Rate = 10.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.36%
[DCF Debug] Terminal Value 86.01% ; FCFF base≈114.0m ; Y1≈125.3m ; Y5≈160.3m
Fair Price DCF = 30.78 (EV 4.28b - Net Debt 772.8m = Equity 3.51b / Shares 114.0m; r=6.21% [WACC]; 5y FCF grow 11.35% → 2.90% )
EPS Correlation: -31.88 | EPS CAGR: 3.01% | SUE: 0.53 | # QB: 0
Revenue Correlation: -7.51 | Revenue CAGR: 5.07% | SUE: 0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.07 | Chg30d=-0.017 | Revisions Net=+0 | Analysts=3
EPS next Year (2026-12-31): EPS=0.61 | Chg30d=+0.012 | Revisions Net=-1 | Growth EPS=+50.0% | Growth Revenue=+4.3%
P/S = 1.5581
P/B = 2.0295
Revenue TTM = 754.0m USD
EBIT TTM = 10.1m USD
EBITDA TTM = 66.8m USD
Long Term Debt = 846.1m USD (from longTermDebt, last quarter)
Short Term Debt = 8.73m USD (from shortLongTermDebt, last quarter)
Debt = 899.2m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 772.8m USD (from netDebt column, last quarter)
Enterprise Value = 2.03b USD (1.21b + Debt 899.2m - CCE 82.0m)
Interest Coverage Ratio = 0.26 (Ebit TTM 10.1m / Interest Expense TTM 39.6m)
EV/FCF = 17.12x (Enterprise Value 2.03b / FCF TTM 118.6m)
FCF Yield = 5.84% (FCF TTM 118.6m / Enterprise Value 2.03b)
FCF Margin = 15.73% (FCF TTM 118.6m / Revenue TTM 754.0m)
Net Margin = -25.54% (Net Income TTM -192.6m / Revenue TTM 754.0m)
Gross Margin = 24.37% ((Revenue TTM 754.0m - Cost of Revenue TTM 570.2m) / Revenue TTM)
Gross Margin QoQ = 25.41% (prev 25.43%)
Tobins Q-Ratio = 1.17 (Enterprise Value 2.03b / Total Assets 1.73b)
Interest Expense / Debt = 0.93% (Interest Expense 8.37m / Debt 899.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = 8.01m (EBIT 10.1m * (1 - 21.00%))
Current Ratio = 2.25 (Total Current Assets 297.1m / Total Current Liabilities 132.1m)
Debt / Equity = 1.48 (Debt 899.2m / totalStockholderEquity, last quarter 607.9m)
Debt / EBITDA = 11.57 (Net Debt 772.8m / EBITDA 66.8m)
Debt / FCF = 6.51 (Net Debt 772.8m / FCF TTM 118.6m)
Total Stockholder Equity = 653.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -10.77% (Net Income -192.6m / Total Assets 1.73b)
RoE = -29.46% (Net Income TTM -192.6m / Total Stockholder Equity 653.7m)
RoCE = 0.68% (EBIT 10.1m / Capital Employed (Equity 653.7m + L.T.Debt 846.1m))
RoIC = 0.52% (NOPAT 8.01m / Invested Capital 1.53b)
WACC = 6.21% (E(1.21b)/V(2.11b) * Re(10.27%) + D(899.2m)/V(2.11b) * Rd(0.93%) * (1-Tc(0.21)))
Discount Rate = 10.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.36%
[DCF Debug] Terminal Value 86.01% ; FCFF base≈114.0m ; Y1≈125.3m ; Y5≈160.3m
Fair Price DCF = 30.78 (EV 4.28b - Net Debt 772.8m = Equity 3.51b / Shares 114.0m; r=6.21% [WACC]; 5y FCF grow 11.35% → 2.90% )
EPS Correlation: -31.88 | EPS CAGR: 3.01% | SUE: 0.53 | # QB: 0
Revenue Correlation: -7.51 | Revenue CAGR: 5.07% | SUE: 0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.07 | Chg30d=-0.017 | Revisions Net=+0 | Analysts=3
EPS next Year (2026-12-31): EPS=0.61 | Chg30d=+0.012 | Revisions Net=-1 | Growth EPS=+50.0% | Growth Revenue=+4.3%